Thyrotropin-releasing hormone: Role in the treatment of West syndrome and related epileptic encephalopathies

Brain and Development

Volumn 23, Issue 7, 2001, Pages 662-667

  Takeuchi, Yoshihiro ^a   Takano, Tomoyuki ^a   Abe, Junko ^a   Takikita, Shoichi ^a   Ohno, Masaki ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Cerebrospinal fluid; Kynurenine; Lennox Gastaut syndrome; Thyrotropin releasing hormone; West syndrome

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; CORTICOTROPIN; PHENOBARBITAL; PHENYTOIN; PROTIRELIN; PROTIRELIN DERIVATIVE; VALPROIC ACID; ZONISAMIDE;

BRAIN INJURY; CONFERENCE PAPER; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EPILEPSY; HUMAN; INFANT; KINDLING; LENNOX GASTAUT SYNDROME; PRESCHOOL CHILD; PSYCHOMOTOR ACTIVITY; WEST SYNDROME;

CHILD; EPILEPSY; HUMANS; INFANT; KYNURENINE; SPASMS, INFANTILE; THYROTROPIN-RELEASING HORMONE;

EID: 0034778333     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(01)00303-5     Document Type: Conference Paper

References (29)

1. Thyrotropin-releasing hormone. Regional distribution in rat brain
2. Regulatory peptides as a source of new drugs - the clinical prospects for analogues of TRH which are resistant to metabolic degeneration
3. Thyroid hormones and antihyperthyroid drugs
4. Pituitary hormones
5. Efficacy of thyrotropin-releasing hormone in the treatment of cerebellar ataxia
6. Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy
7. Effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration
8. A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report
9. Thyroptropin-releasing hormone: role in the treatment of epilepsy
10. Thyrotropin-releasing hormone (TRH) in the treatment of intractable epilepsy
11. Reversible cerebral atrophy caused by corticotropin
12. Reversible cerebral atrophy in infantile spasms caused by corticotropin
13. ACTH therapy in infantile spasms: side effects
14. Clinical effects of thyrotropin-releasing hormone for severe epilepsy in childhood: a comparative study with ACTH therapy
15. Factors influencing the effectiveness of thyrotropin-releasing hormone therapy for severe epilepsy in childhood: significance of serum prolactin levels
16. Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites
17. TRH increases cerebrospinal fluid concentration of kynurenine
18. Monoamine metabolites in the cerebrospinal fluid in infantile spinal muscular atrophy
19. Developmental changes in CSF concentrations of monoamine-related substances revealed with a coulochem electrode array system
20. Developmental changes in CSF concentrations of monoamine-related substances in patients with DRPLA
21. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors
22. Quinolinic acid and other kynurenines in the central nervous system
23. Brain-specific modulation of kynurenic acid synthesis in the rat
24. Kynurenine pathway abnormalities in Parkinson's disease
25. Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate
26. Studies on CSF tryptophan metabolism in infantile spasms
27. Tryptophan degradation to control T-cell responsiveness
28. Indoleamine 2,3-dioxygenase reduction by human dendritic cells results in the inhibition of T cell proliferation
29. Tryptophan degradation and immune activation in Alzheimer's disease